ES2899185T8 - Cepas probióticas que tienen capacidad de absorción de colesterol, procedimientos y usos de las mismas - Google Patents

Cepas probióticas que tienen capacidad de absorción de colesterol, procedimientos y usos de las mismas

Info

Publication number
ES2899185T8
ES2899185T8 ES15808180T ES15808180T ES2899185T8 ES 2899185 T8 ES2899185 T8 ES 2899185T8 ES 15808180 T ES15808180 T ES 15808180T ES 15808180 T ES15808180 T ES 15808180T ES 2899185 T8 ES2899185 T8 ES 2899185T8
Authority
ES
Spain
Prior art keywords
procedures
absorption capacity
cholesterol absorption
probiotic strains
probiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES15808180T
Other languages
English (en)
Other versions
ES2899185T3 (es
Inventor
Otero Ana Isabel Sanudo
Garcia Raquel Criado
Nogales Alba Rodriguez
Domech Alberto Garach
Martin Mónica Olivares
Peralta Julio Juan Galvez
La Escalera Hueso Santiago De
Perez Juan Manuel Duarte
Zurita Antonio Zarzuelo
Hortigüela Oscar Banuelos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosearch SA
Original Assignee
Biosearch SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosearch SA filed Critical Biosearch SA
Application granted granted Critical
Publication of ES2899185T3 publication Critical patent/ES2899185T3/es
Publication of ES2899185T8 publication Critical patent/ES2899185T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ES15808180T 2014-12-10 2015-12-10 Cepas probióticas que tienen capacidad de absorción de colesterol, procedimientos y usos de las mismas Active ES2899185T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14384202.9A EP3031930A1 (en) 2014-12-10 2014-12-10 Probiotic strains having cholesterol absorbing capacity, methods and uses thereof
PCT/EP2015/079298 WO2016092032A1 (en) 2014-12-10 2015-12-10 Probiotic strains having cholesterol absorbing capacity, methods and uses thereof

Publications (2)

Publication Number Publication Date
ES2899185T3 ES2899185T3 (es) 2022-03-10
ES2899185T8 true ES2899185T8 (es) 2022-05-26

Family

ID=52396401

Family Applications (1)

Application Number Title Priority Date Filing Date
ES15808180T Active ES2899185T3 (es) 2014-12-10 2015-12-10 Cepas probióticas que tienen capacidad de absorción de colesterol, procedimientos y usos de las mismas

Country Status (14)

Country Link
US (1) US11058734B2 (es)
EP (2) EP3031930A1 (es)
JP (1) JP6707087B2 (es)
CN (1) CN107438664B (es)
AU (1) AU2015359382B2 (es)
BR (1) BR112017012251A2 (es)
CA (1) CA2970602C (es)
ES (1) ES2899185T3 (es)
HU (1) HUE057081T2 (es)
MX (1) MX2017007654A (es)
PL (1) PL3230479T3 (es)
RS (1) RS62610B1 (es)
RU (1) RU2722038C2 (es)
WO (1) WO2016092032A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106434427A (zh) * 2016-08-29 2017-02-22 中国疾病预防控制中心传染病预防控制所 乳酸杆菌益生菌cgmcc no.12421及在制备降脂药物中的应用
US11596657B2 (en) * 2016-10-04 2023-03-07 Institut National De La Recherche Agronomique Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders
JP7220677B2 (ja) * 2017-06-09 2023-02-10 サミ－サビンサ グループ リミテッド バチルス・コアグランスの脂質低下効果
CN111954536A (zh) * 2018-03-23 2020-11-17 森永乳业株式会社 用于预防学龄期及之后的高血糖引起的疾病的婴幼儿用组合物
CN112646832B (zh) * 2020-12-25 2022-06-21 上海理工大学 一种调节植物乳杆菌黏附能力的方法
CN114344344B (zh) * 2022-01-05 2023-06-13 东北农业大学 罗伊氏乳杆菌在缓解高脂饮食诱导小鼠肥胖功能中的应用及含有罗伊氏乳杆菌的复合物
CN116121146B (zh) * 2023-03-09 2024-01-30 四川大学 一株产乳酸能力较强的戊糖片球菌及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3777296B2 (ja) * 2000-09-04 2006-05-24 明治製菓株式会社 乳酸菌によるコレステロールの低減若しくは除去方法
WO2002027016A2 (en) * 2000-09-25 2002-04-04 The United States Of America, Represented By Secretary, Department Of Health And Human Services Gene involved in dietary sterol absorption and excretion and uses therefor
WO2004076657A2 (en) * 2003-02-28 2004-09-10 Mcgill University Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides
KR100691863B1 (ko) * 2004-12-07 2007-03-13 김홍렬 비피도박테리움 비피둠의 공배양을 통한 콜레스테롤 흡수 저하방법 및 이를 이용한 콜레스테롤 저하제
JP4662443B2 (ja) * 2005-02-14 2011-03-30 明治乳業株式会社 コレステロール低減乳酸菌
JP4336992B2 (ja) * 2006-01-20 2009-09-30 日清食品ホールディングス株式会社 血中コレステロール低減作用を有する新規乳酸菌
EP2311473A1 (en) * 2009-10-09 2011-04-20 AB-Biotics Producciones Industriales De Microbiotas, S.L. Lactobacillus plantarum strains as probiotics
CN102028713A (zh) * 2010-12-12 2011-04-27 夏学德 一种用于降低血清胆固醇的益生菌制剂及其制备方法
ITMI20110792A1 (it) * 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.

Also Published As

Publication number Publication date
US11058734B2 (en) 2021-07-13
PL3230479T3 (pl) 2022-05-09
EP3031930A1 (en) 2016-06-15
WO2016092032A1 (en) 2016-06-16
CN107438664B (zh) 2021-07-30
EP3230479A1 (en) 2017-10-18
AU2015359382A1 (en) 2017-07-27
CA2970602C (en) 2024-03-12
RU2722038C2 (ru) 2020-05-26
RS62610B1 (sr) 2021-12-31
CA2970602A1 (en) 2016-06-16
RU2017121227A (ru) 2019-01-10
MX2017007654A (es) 2018-05-04
BR112017012251A2 (pt) 2018-01-30
AU2015359382B2 (en) 2021-09-02
US20170333495A1 (en) 2017-11-23
EP3230479B1 (en) 2021-10-06
JP2018503367A (ja) 2018-02-08
CN107438664A (zh) 2017-12-05
ES2899185T3 (es) 2022-03-10
RU2017121227A3 (es) 2019-05-28
JP6707087B2 (ja) 2020-06-10
HUE057081T2 (hu) 2022-04-28

Similar Documents

Publication Publication Date Title
FIC20230014I1 (fi) Foslevodopa ja foskarbidopa
HK1244937A1 (zh) 資產健康評分及其使用
BR112017002232A2 (pt) combinações de inibidor de tirosina quinase de bruton e usos das mesmas
SG11201608179PA (en) Fast viscoacoustic and viscoelastic full-wavefield inversion
DK3261589T3 (da) Lagdelte medicinske indretninger
DK3099172T3 (da) Modificeret biologisk bekæmpelsesmiddel og anvendelser deraf
BR112016016289A2 (pt) heteroaris e usos dos mesmos
ES2899185T8 (es) Cepas probióticas que tienen capacidad de absorción de colesterol, procedimientos y usos de las mismas
BR112015014063A2 (pt) anticorpos anti-b7-h4 humano e seus usos.
DK3141199T3 (da) Medicinsk mikrorobot og mikrorobotsystem med samme
MA40933A (fr) Difluorométhyl-aminopyridines et difluorométhyl-aminopyrimidines
BR112016018062A2 (pt) compostos terapêuticos, composição farmacêutica e usos
HK1245299A1 (zh) 血腦屏障轉運分子及其用途
SG11201609490QA (en) Polymer-flavonoid conjugate and uses thereof
BR112016024298A2 (pt) compostos de quinoxalina e seus usos.
BR112015005789A2 (pt) Formulações que compreende idebenona, n-acetil- s-farnesil-l-cisteína e ergotioneína e usos das mesmas
BR112016027379A2 (pt) formulações tópicas e seus usos
BR112017013012A2 (pt) compostos de indenil, composições farmacêuticas e usos médicos destes
BR112016026552A2 (pt) derivados de carboxamida, seus usos, composição farmacêutica, e combinação
DK3166473T3 (da) Oftalmoskoper
PL3040062T3 (pl) Struktura chłonna i artykuł chłonny, zawierający tę strukturę chłonną
BR112016027383A2 (pt) Derivados de naftiridinadiona, seus usos, composição farmacêutica e combinação
BR112017018932A2 (pt) etv2 e usos do mesmo
DK3114118T3 (da) p-SUBSTITUEREDE ASYMMETRISKE URINSTOFFER OG MEDICINSK ANVENDELSE DERAF
DK3083678T3 (da) Midler og fremgangsmåder til at modvirke myeloproliferative eller lymfoproliferative forstyrrelser